skip to Main Content

SBIR Award: Integrated BioTherapeutics

  • July 22, 2015

SBIR Award: Integrated BioTherapeutics to Create Therapeutic Multi-Specific Antibodies Using Technology from Zyngenia Integrated Biotherapeutics (IBT) has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division…

Read More

SBIR Award: Integrated BioTherapeutics

  • July 22, 2015

Integrated BioTherapeutics (IBT) has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the NIH. The company will receive $550,000 for work to take place…

Read More

New Publication from the Researchers at IBT

  • July 22, 2015

Efforts to develop effective vaccines against Staphylococcus aureus (S. aureus) have been largely unsuccessful, in part due to the variety of virulence factors produced by this organism. Recently, researchers lead by Dr. Rajan Adhikari at IBT have published a paper…

Read More
Back To Top
×Close search
Search